Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Guorui Properties Ltd ( (HK:2329) ) is now available.
Glory Health Industry Limited reported that contracted sales for 2025 reached RMB2,122.7 million, while revenue from property development was RMB606.6 million amid pressure in the rental market. The company’s total revenue fell to RMB1,035.6 million from RMB2,705.3 million in 2024, contributing to a widened annual loss of RMB1,769.4 million despite a positive change in the fair value of investment properties.
The group’s land reserves totaled 6.2 million square meters of gross floor area at year-end 2025, with 51% of certified saleable land reserves concentrated in Beijing, underscoring its strategic focus on that market. However, higher finance costs, increased impairment losses, and net other losses weighed heavily on profitability, signaling continued financial and operational challenges for stakeholders despite a sizable land bank and ongoing contracted sales.
The most recent analyst rating on (HK:2329) stock is a Hold with a HK$0.13 price target. To see the full list of analyst forecasts on Guorui Properties Ltd stock, see the HK:2329 Stock Forecast page.
More about Guorui Properties Ltd
Glory Health Industry Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the property development and investment sector. The group focuses on property development and rental operations, with a significant portion of its certified saleable land reserves located in Beijing, and a total land bank of 6.2 million square meters as of the end of 2025.
YTD Price Performance: -18.11%
Average Trading Volume: 437,448
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$462.2M
See more insights into 2329 stock on TipRanks’ Stock Analysis page.